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Abstract. We report the clinical findings, epidemiology, and risk factors for moderate-to-severe diarrhea (MSD)
associated with Aeromonas species in children 0–59 months of age, from the Global Enteric Multicenter Study,
conducted at three sites in south Asia and four sites in sub-Saharan Africa. Children with MSD were enrolled along
with controls matched for age, gender, and neighborhood. Pooled, age-stratified conditional logistic regression models
were applied to evaluate the association of Aeromonas infection controlling for coinfecting pathogens and socio-
demographic variables. A pooled, age-stratified, multivariate logistic regression analysis was done to identify risk fac-
tors associated with Aeromonas positivity in MSD cases. A total of 12,110 cases and 17,291 matched controls were
enrolled over a period of 48 months. Aeromonas was identified as a significant pathogen in 736 cases of MSD in
Pakistan and Bangladesh (22.2%). Aeromonas remained a significant pathogen even after adjustment for the presence
of other pathogens and sociodemographic factors. Odds ratio (OR) for Aeromonas were higher in the presence of
Shigella (matched OR: 6.2, 95% confidence interval [CI]: 1.9–20.2). Cases of Aeromonas were likely to present with
dysentery, particularly in the 0–11 months (OR: 1.4, 95% CI 1.0–2.0) and 12–23 months (OR: 1.8, 95% CI: 1.3–2.5) age
group. The odds of Aeromonas increased with increasing degree of stunting, being highest for severe stunting (OR:
10.1, 95% CI: 3.6–28.9). Aeromonas is a significant pathogen for MSD in Pakistan and Bangladesh. Presence of dysentery
and co-occurrence with other pathogens, notably Shigella spp. are significant features of Aeromonas-associated diarrhea.
INTRODUCTION
Aeromonas species are motile, gram-negative facultative
anaerobic bacilli that cause gastroenteritis. They are wide-
spread in nature, found in soil as well as aquatic environ-
ments. They are emerging as human pathogens, and are
commonly isolated from diarrheal specimens in tropical coun-
tries.1 Aeromonas was first identified in human feces in 1961.2
Some case–control studies have demonstrated an epidemio-
logic association between diarrhea in young infants and
children3,4 while others have not.5 Methodological issues
(e.g. short period of surveillance, controls not matched for
age or season), asymptomatic shedding, and failure to con-
sider differences in pathogenicity according to genospecies
of known virulence factors may have contributed to varia-
tion in results. In various case–control studies, Aeromonas
has been identified as a pathogen in 1–88% of children
with diarrhea and in 0–45% of controls.6 The reported rates
differ depending on the use of culture methods, species
identification methods, and inclusion or exclusion of other
diarrheal co-pathogens.1 There is also a wide geographical
variation in the reported frequency of isolation and associa-
tion with diarrhea.6
In most cases of gastroenteritis, Aeromonas is a co-pathogen,
isolated along with other enteric pathogens.7 Most (90%) cases
of acute Aeromonas-associated diarrhea (AAD) are tran-
sient and self-limiting, but dysentery and severe cholera-like
diarrhea due to Aeromonas have been described and may
require treatment with antibiotics.6 Despite these anecdotal
descriptions, Aeromonas pathogenicity and virulence still
remains in question.8
There is a need for well-designed epidemiological studies.
AAD was described recently by the Global Enteric Multi-
center Study (GEMS), which was designed to measure
burden, microbial etiology, and nutritional effects of
moderate-to-severe diarrhea (MSD) in developing countries.9
Attributable fractions (AFs) for enteropathogens were
derived from the first 36 months of GEMS data collec-
tion. Aeromonas spp. were a major pathogen for diarrhea
in Pakistan and Bangladesh with the highest AF among chil-
dren of 24–59 months of age, where the AF for AAD in
Bangladesh was 18.3 (95% confidence interval [CI]: 10.8–
25.9) and for Pakistan it was 24.1 (95% CI: 16.0–32.3).10 We
present the distribution of Aeromonas among cases and con-
trols in children 0–59 months of age in all seven GEMS sites
over 48 months and odds ratios (ORs) for Aeromonas MSD
adjusted for other pathogens and socioeconomic factors.
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We also describe clinical and sociodemographic predictors
for AAD among MSD cases.
METHODS
Primary study. The GEMS was an age-stratified, case–
control study. Three age strata of 0–11, 12–23, and 24–
59 months were studied. Each of seven sites in Asia and sub-
Saharan Africa (Bangladesh, India, Pakistan, Mozambique,
Mali, The Gambia, and Kenya) included one to 11 commu-
nity Sentinel Health Centers serving censused populations.
Children were defined as having diarrhea if they fit the
World Health Organization definition of > 3 loose stools per
day, and were included as cases if diarrhea represented a
new episode (no episodes in preceding 7 days) and was mod-
erate to severe (with any one of the following: sunken eyes,
loss of skin turgor, dysentery, need for intravenous rehydra-
tion, or hospitalization). For each case of MSD, —one to
three matched community controls were randomly selected
from the censused population at each site. Controls were
children with no episode of diarrhea in the 7 days preceding
enrollment. In addition, they were selected on the basis of
the following matching criteria: age + 2 months for age group
0–11 months, +4 months for age group 12–59 months, and
not exceeding stratum boundaries for age group of case,
same gender, residence in same catchment area, and enroll-
ment within 14 days of that of corresponding case. Further
details regarding clinical and epidemiological design of the
GEMS and its Health Care Utilization and Attitudes Surveys
have been described by Kotloff and others.9
GEMS was carried out for a total of 48 months, initially
from 2009 to 2011 and for an additional 12 months in 2012.
Microbiological methods for detection of Aeromonas
species. In GEMS, an extensive workup for a wide array
of putative and established viral, bacterial, and protozoal
diarrheal pathogens was undertaken on each case and con-
trol specimen at the local site laboratories, as described by
Panchalingam and others.11 These laboratories followed stan-
dard protocols, which were ensured by site supervisors and
site visits by study personnel. Rigorous quality control and
quality assurance procedures were implemented to ensure
robustness of procedures.
In brief, stool specimens for detection of Aeromonas were
collected at the field sites in Cary Blair tubes, plated on Ryan
medium, and incubated aerobically at 35–37°C for 48 hours.
After 48 hours, all dark green colonies with darker centers on
Ryan medium were characterized further by testing for pres-
ence of oxidase, catalase, salt tolerance, and O129 susceptibil-
ity. Oxidase-positive, catalase-producing, salt-intolerant, and
O129-resistant colonies were identified as Aeromonas spp.
Antimicrobial susceptibility tests were not performed.
Statistical analysis. Operational definitions. For the purpose
of statistical analysis, Aeromonas positivity among cases was
defined either as AAD or Aeromonas-only diarrhea (AOD).
AAD: All MSD cases where Aeromonas was isolated
from stool cultures, regardless of the co-occurrence of
other pathogens.
AOD: All MSD cases where Aeromonas was isolated as a
sole pathogen.
For the parent study, a matched case–control analysis using
conditional logistic regression (CLR) modeling and MSD as
outcome was carried out to identify pathogens associated with
MSD across the seven sites and three age strata. Adjusted
ORs (AORs) were used to calculate the AF of each pathogen
identified as a risk factor. These have been reported else-
where.10 Statistical analytic methods used in the parent study
have been described by Blackwelder and others.12
Matched case–control analysis. To evaluate the association
of Aeromonas stool positivity with MSD, and to determine
how this association is affected by other factors, we per-
formed an age-stratified CLR analysis for Bangladesh and
Pakistan. Matched AORs were calculated for Aeromonas.
Three models were built stratified by age groups with
Aeromonas as the main exposure variable. Model 1 was
adjusted for pathogens, Model 2 was adjusted for socioeco-
nomic variables, and Model 3 was adjusted for both patho-
gens and sociodemographic variables. All covariates that
occurred greater than five times and had P < 0.10 in CLR
model for individual covariate were put in the multivariable
model. A backward elimination process was used to derive
a parsimonious model with all variables having a P value
≤ 0.05. All variables that co-occurred with Aeromonas
≥ 10 times in cases or controls were tested for interaction.
All interaction terms with a P value of ≤ 0.05 were retained
in the model.
Within-case logistic regression analysis. To determine clini-
cal, microbiological, and environmental predictors of AAD,
we performed a within-case logistic regression analysis for
Aeromonas positivity among MSD cases stratified by age.
We also pooled MSD cases from Bangladesh and Pakistan
within their respective age strata. All variables with a
P value ≤ 0.1 in the univariate analysis were used to build
amultivariable model. A backward selection procedure was
used to derive a parsimonious model for each age stratum,
retaining only variables significant at P value ≤ 0.05.
Ethical approval. The parent study was approved by the
Ethical Review Committee of all sites and the Institutional
Review Board of the University of Maryland, Baltimore,
MD. Signed and written informed consents were collected
from all participants. The parent or primary caretaker
received a copy of the signed consent form to keep, and the
original was stored in the regulatory files at the study site.
Data were stored anonymously to ensure confidentiality.
RESULTS
A total of 12,110 children with MSD plus 17,291 matched
controls without diarrhea were enrolled at seven sites over a
period of 60 months. Figure 1 describes the distribution
of Aeromonas spp. in stool samples of cases and controls
across all sites, stratified by age group. Aeromonas spp.
BOX 1
Lessons from the GEMS Aeromonas experience
a. Aeromonas was significantly associated with SD in 2 of
7 GEMS sites, i.e., Pakistan and Bangladesh
b. Aeromonas often presents with dysentery in children 0–59
months of age
c. Strength of association of Aeromonas with MSD increases in
the presence of Shigella
d. Strength of association of Aeromonas with MSD increases
with degree of stunting
GEMS = Global Enteric Multicenter study; MSD = moderate-to-severe diarrhea.
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were recovered from stool cultures in > 1% of cases and
controls from Pakistan and Bangladesh sites only.1 Results
of the matched case–control analysis from all seven GEMS
sites are presented elsewhere.12
During the study 1,460, 1,091, and 761 MSD cases in age
groups of 0–11, 12–23, and 24–59 months, respectively, were
enrolled in both Pakistan and Bangladesh combined. Stool
culture positivity rate for Aeromonas spp. among diarrheal
specimens from cases was 18.7% (N = 273) in the 0–11 months
age group, 22.5% (N = 245) in the 12–23 months age group,
and 28.6% (N = 218) in the 24–59 months age group in
Pakistan and Bangladesh. Aeromonas spp. were isolated as a sole
pathogen from only 2.3% (N = 35) of cases aged 0–11 months,
1.8% (N = 20) of cases aged 12–23 months, and 4.2% (N =
32) of cases aged 24–59 months. Of these AOD cases, 65.7%
(N = 23), 80% (N = 16), and 59.4% (N = 19) presented with
blood in their stools from among the 0–11, 12–23, and 24–
59 months age strata. Clinical features of AOD compared
with MSD due to all other pathogens are provided in Supple-
mental Appendix, Supplemental Tables 1 and 2. Diarrheal
stool specimens from cases were negative for all entero-
pathogens in 9.1% (N = 133) of 0–11 months of age group,
4.5% (N = 50) of 12–23 months age group, and 6.0% (N = 46)
of 24–59 months age group.
Association of Aeromonas with MSD and effect of patho-
gens and SE factors. Table 1 presents matched ORs (mORs)
FIGURE 1. Distribution of Aeromonas among cases with moderate to severe diarrhea and their matched controls across seven sites and three
age strata.
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for AAD derived from four separate models. After adjusting
for other enteropathogens and socioeconomic factors,
Aeromonas remained a significant pathogen across all age
strata in both sites as well as in the pooled analysis. In
the model adjusted for both other pathogens and socio-
demographic variables (Model 3), Aeromonas had an inter-
action with Shigella species driven by the Pakistan site in age
group 2. The mORs for Aeromonas were higher in the pres-
ence of Shigella (mOR: 1.4, 95% CI: 0.9–2.2 versus mOR:
8.0, 95% CI: 1.5–43.8) in Pakistan. This interaction was also
seen when data from Bangladesh and Pakistan were pooled.
In age group 3, there was an interaction with nutritional
status at Pakistan site, mOR for Aeromonas increased
with increasing degree of stunting (Figure 2).
In age group 3, mOR for Aeromonas was higher in Pakistan
than in Bangladesh (mOR: 3.7, 95% CI: 2.3–6.0 versus
mOR: 2.3, 95% CI: 1.4–3.9). This also manifested as an inter-
action with site in the pooled analysis.
Clinical, microbiological, and environmental predictors of
AAD. Table 2 presents results for the multivariate analysis
FIGURE 2. Interaction of moderate-to-severe diarrhea due to
Aeromonas with nutritional status (height-for-age Z score) in chil-
dren aged 24–59 months in Pakistan.
TABLE 1
Site-specific and pooled (both Pakistan and Bangladesh) mAORs for association of MSD with Aeromonas adjusted for pathogens and socioeco-
nomic variables
Bangladesh Pakistan Pooled
OR (95% CI) P value OR (95% CI) P value OR (95% CI) P value
Model 0
0–11 2.0 (1.5–2.6) < 0.001 2.1 (1.5–2.9) < 0.001 2.0 (1.7–2.5) < 0.001
12–23 2.0 (1.5–2.7) < 0.001 2.2 (1.6–3.0) < 0.001 2.1 (1.7–2.6) < 0.001
24–59 2.4 (1.8–3.2) < 0.001 3.6 (2.5–5.0) < 0.001 2.8 (2.3–3.5) < 0.001
Model 1
0–11 1.7 (1.3–2.4) 0.001 2.3 (1.5–3.4) < 0.001 1.9 (1.5–2.5) < 0.001
12–23 1.9 (1.2–3.0) 0.005 2.0 (1.4–2.9) < 0.001 2.0 (1.5–2.6)
Aeromonas × Shigella Aeromonas × Shigella
Shigella negative, 1.8 (1.2–2.6) 0.002 Shigella negative, 1.8 (1.4–2.4) < 0.001
Shigella positive, 9.6 (1.8–51.3) 0.008 Shigella positive, 5.8 (1.9–18.1) 0.003
24–59 2.4 (1.5–3.9) < 0.001 3.9 (2.6–5.9) < 0.001 3.3 (2.4–4.5) < 0.001
Aeromonas × site
Bangladesh, 2.3 (1.5–3.5) < 0.001
Pakistan, 4.8 (3.0–7.5) < 0.001
Model 2
0–11 1.9 (1.5–2.5) < 0.001 2.2 (1.6–3.0) < 0.001 2.0 (1.6–2.5) < 0.001
Aeromonas × age
≤ 6 month, 3.8 (1.7–8.2) < 0.001
> 6 months, 1.1 (0.6–2.3) 0.706
12–23 2.1 (1.6–2.8) < 0.001 1.8 (1.3–2.6) 0.001 2.0 (1.6–2.6) < 0.001
24–59 2.5 (1.8–3.4) < 0.001 3.6 (2.3–5.4) 0.001 2.7 (2.1–3.5) < 0.001
Aeromonas × HAZ
Well-nourished, 1.3 (0.3–4.8) 0.705
Mild stunting, 1.9 (0.8–4.4) 0.128
Mod stunting, 3.6 (1.8–7.0) < 0.001
Severe stunting, 11.8 (4.4–32.0) < 0.001
Model 3
0–11 1.8 (1.3–2.4) 0.001 2.3 (1.6–3.5) < 0.001 1.9 (1.4–2.5) < 0.001
12–23 2.0 (1.2–3.1) 0.003 1.7 (1.1–2.5) 0.013 1.8 (1.3–2.5) < 0.001
Aeromonas × Shigella Aeromonas × Shigella
Shigella negative, 1.4 (0.9–2.2) 0.097 Shigella negative, 1.6 (1.2–2.3) 0.002
Shigella positive, 8.0 (1.5–43.8) 0.016 Shigella positive, 6.2 (1.9–20.2) 0.002
24–59 2.3 (1.4–3.9) 0.002 3.7 (2.3–6.0) < 0.001 3.0 (2.1–4.2) < 0.001
Aeromonas × HAZ Aeromonas × site
Well nourished, 1.0 (0.3–4.2) 0.950 Bangladesh, 2.2 (1.3–3.5) 0.002
Mild stunting, 2.0 (0.8–5.3) 0.141 Pakistan, 4.0 (2.5–6.6) < 0.001
Mod stunting, 4.3 (2.1–9.0) < 0.001
Severe stunting, 10.1 (3.6–28.9) < 0.001
CI = confidence interval; ETEC = enterotoxigenic E. coli; EHEC = enterohaemorrhagic E. coli; EAEC = entero-adherent E. coli; EPEC = enteropathogenic E. coli; HAZ = height-for-age
Z score; mAORs = matched adjusted odds ratios; MSD = moderate-to-severe diarrhea; OR = odds ratio. Model 0 represents unadjusted analysis. Model 1 is adjusted for Shigella, Salmonella,
Campylobacter, ETEC, EHEC, EAEC, EPEC, Adenovirus, Vibrio cholera, Cryptosporidium, Giardia, Entameoba histolytica, Norovirus GI, Norovirus GII, Astrovirus, Sapovirus, and Rotavirus
(cumulative list of pathogens that were adjusted across all models). Model 2 is adjusted for sociodemographic variables (wealth quintiles, water supply, treatment of drinking water, type of floor-
ing, number of children under 5 years in household, breastfeeding, HAZ, animals in household). Model 3 is adjusted for pathogens and sociodemographic variables.
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for predictors of AAD, pooled for Bangladesh and Pakistan.
Site-specific analysis is presented as a Supplemental Appen-
dix, Supplemental Tables 1 and 2. In the 0–11 months age
group, AAD cases were more likely to be not breastfed
(OR: 0.4, 95% CI: 0.3–0.6), present with dysentery (OR: 1.4,
95% CI: 1.0–2.0) and abdominal pain (OR: 1.5, 95% CI: 1.1–
2.1), more likely to have received home-based fluid therapy
(OR: 2.6, 95% CI: 1.1–6.0), and more likely to co-occur with
nontyphoidal Salmonella (NTS) (OR: 2.1, 95% CI: 1.1–4.0).
In 12–23 months age group, AAD cases were again more
likely to be not breastfed (OR: 0.6, 95% CI: 0.4–0.9) and
more likely to present with dysentery (OR: 1.8, 95% CI: 1.3–
2.5). There were no significant predictors identified in the
third age group.
Speciation of Aeromonas was performed by the Sanger
Institute, and 131 Aeromonas isolates were sequenced. Pre-
liminary data show that they belong to the following species:
Aeromonas caviae (42 cases and 42 controls), Aeromonas
dhakensis (7 cases and 3 controls), Aeromonas veronii (11 cases
and 17 controls), Aeromonas enteropelogenes (4 cases and
2 controls), and Aeromonas sanarelli (1 case and 0 control).
The sequence of one isolate did not match any of the 141 ref-
erences present in the databases.
DISCUSSION
Aeromonas was significantly associated with MSD among
children less than 5 years of age at two Asian sites: Karachi,
Pakistan, and Mirzapur, Bangladesh. Aeromonas was sig-
nificantly associated with MSD in all age groups and after
controlling for the presence of co-pathogens and for socio-
demographic variables that might increase the risk of MSD.
Our findings further illustrate a remarkable geographic vari-
ation in the importance of Aeromonas as a diarrheal patho-
gen. While Aeromonas was identified in < 1% of cases and
controls in all age strata from the African sites and Kolkata,
India, it was identified in 18.7% of infants, 22.5% of toddlers
12–23 months of age, and 28.6% of children 24–59 months
of age. The association was seen at the two sites individu-
ally and when the data were pooled, all with a trend toward
increasing frequency with age.
Past studies evaluating whether Aeromonas is significantly
associated with childhood diarrhea have yielded conflicting
results. Some case–control studies have demonstrated an epi-
demiologic association with diarrhea in infants and children3
while others have not.5,13 Factors that may have contrib-
uted to study-to-study variation include methodological
issues (e.g. short period of surveillance, failure to account
for differences in cases and controls in factors such as age or
season), carriage rates in asymptomatic children that were
similar to diarrhea patients in some settings, geographic vari-
ability in disease incidence, and failure to account for differ-
ences in pathogenicity according to genospecies or known
virulence factors. In addition, bias may be introduced when
the impact of coinfection with other pathogens is not con-
sidered. Finally, there may be host factors that influence
the pathogenicity of Aeromonas in various settings, such as
genetic predilection, the prevalence of underlying stunting,
a risk factor in our study, or high environmental exposure
due to predisposing factors such as contamination of drink-
ing water. GEMS overcame many of these issues by using
standardized methods in a 36-month study conducted at
seven sites in Africa and Asia and performing analyses
that controlled for the presence of co-pathogens and eval-
uated associations in episodes from which Aeromonas was
the only pathogen identified. The absence of these con-
founding factors strengthens our epidemiologic observation
that Aeromonas is significantly associated with watery diar-
rhea and dysentery among children under 5 years of age in
Bangladesh and Pakistan.
Of the several risk factors for Aeromonas evaluated in
GEMS, we were able to identify lack of breastfeeding as a
significant risk factor in pooled analysis from Pakistan and
Bangladesh. Breast milk contains factors such as secretory
IgA and oligosaccharides that prevent both pathogen-specific
(e.g., Shigella and rotavirus) and nonspecific diarrheal illness.
Moreover, reliance of breastfeeding may prevent exposure
to contaminated food and water. A lack of breastfeeding
necessitates feeding with either animal-source milk, which is
diluted with water before being fed to babies, or other food
prepared with water.
An interesting feature of AAD is the occurrence of
co-pathogens. In the present study, NTS and Shigella spp.
TABLE 2
Multivariate model of predictors of Aeromonas positivity among MSD cases in Bangladesh and Pakistan
0–11 months cases (N = 1,460) 12–23 months cases (N = 1,091) 24–59 months cases (N = 761)
OR
95% CI
P value OR
95% CI
P value OR
95% CI
P valueLower Upper Lower Upper Lower Upper
Model 1
Shigella species 1.6 1.1 2.3 0.023 1.5 1.1 2.0 0.010 – – – –
NTS 2.87 1.62 5.09 < 0.001 – – – – – – – –
Model 2
Breastfed 0.4 0.3 0.6 < 0.001 0.6 0.4 0.9 0.008 – – – –
Dysentery 1.5 1.1 2.1 0.022 2.1 1.5 2.9 < 0.001 – – – –
Abdominal pain 1.5 1.1 2.1 0.019 – – – – – – – –
Rehydrated with homemade fluid 2.8 1.2 6.4 0.016 – – – – – – – –
Model 3
NTS 2.1 1.1 4.0 0.026 – – – – – – – –
Breastfed 0.4 0.3 0.6 < 0.001 0.6 0.4 0.9 0.024 – – – –
Dysentery 1.4 1.0 2.0 0.04 1.8 1.3 2.5 0.001 – – – –
Abdominal pain 1.5 1.1 2.1 0.026 – – – – – – – –
Rehydrated with homemade fluid 2.6 1.1 6.0 0.025 – – – – – – – –
CI = confidence interval; NTS = nontyphoidal Salmonella; OR = odds ratio.
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showed a significant association with AAD particularly in
the younger age groups. In some studies Aeromonas is
commonly part of a polymicrobial infection, which raises
the question of whether it is behaving as a nonpathogenic
“co-traveler” perhaps acquired from the same source as the
true pathogen, or is interacting with other agents to cause
disease. Pathogens commonly reported in literature to coex-
ist with Aeromonas are rotavirus, Vibrio spp., Shigella, Cam-
pylobacter, and Escherichia coli O157:H7.4,13–15
Overall, Aeromonas comprised 22.7% of episodes of
watery diarrhea and 26.3% of episodes of dysentery at these
two sites. The proportion of cases manifesting as bloody
diarrhea increased with age, from 42.4% of infants to
∼754.6% of those 1 year or older. However, Aeromonas
was associated with dysentery only in the lower two age
strata. This association between Aeromonas spp. and dysen-
tery has been observed by others.16,17 Lending biological
plausibility to the relationship between Aeromonas and dys-
entery is the observation that Aeromonas isolates from two
patients with dysentery were invasive and able to replicate
intracellularly in HEp-2 cell assays.18 Moreover, a cytotoxic
enterotoxin Act from a human Aeromonas hydrophila iso-
late causes epithelial destruction in mouse ligated intesti-
nal loops19 and elicits inflammatory responses, features that
might produce dysentery in humans.
There are several limitations of this study. It is possible
that there were coinfecting organisms such as Shigella that
were not cultivated but were responsible for some propor-
tion of the diarrheal symptoms observed. Further investi-
gations using molecular diagnostics in children with MSD
and their controls may shed additional light on this issue.
The parent study was designed to detect pathogens for
MSD and not powered for risk factors for individual patho-
gens. Second, although we know from reviewing the litera-
ture that A. hydrophila, Aeromonas sobria, and A. caviae
are the species most frequently implicated in diseases of
humans, we did not perform speciation of Aeromonas.
Although this is unlikely to affect the results of the study,
speciation may help to differentiate environmental from
pathogenic strains.
CONCLUSIONS
Aeromonas is significantly associated with MSD, causing
both watery diarrhea and dysentery among children under
5 years of age in Pakistan and Bangladesh but not in other
geographic areas in Asia and sub-Saharan Africa, demon-
strating its considerable geographic variability. Risk factors
for AAD are similar to those of other bacterial pathogens.
Presence of dysentery and co-occurrence with Shigella are
significant features of AAD.
In the face of continued resource constraints and poor pol-
icy making, low-cost, “enabling” measures such as organized
health education at community level to promote breast-
feeding and standardized home-based water purification
can be effective in AAD prevention. Furthermore, large
community-based, pathogen-specific studies are important to
understand the epidemiology and distribution of AAD to enable
development of effective programs for disease prevention.
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